Pillar 1 aims to aggregate and communicate market insights to improve vaccine market health by facilitating decision-making by manufacturers, investors and partners, particularly regarding vaccine investments and product portfolio selection.

In close collaboration with Vaccine Alliance partners, Gavi has identified vaccine markets where opportunities exist to strengthen global market health. These markets are prioritised within Gavi's broader regional manufacturing strategy, particularly for the African Vaccine Manufacturing Accelerator (AVMA).

To execute Pillar 1, Gavi has developed a vaccine markets dashboard. This dashboard compiles Gavi's market analysis, UNICEF procurement information and Global Vaccine Market Model (GVMM) forecasts to enhance transparency, access to market information, and stakeholders’ ability to make informed decisions.